Clinical effectiveness of tumor markers in squamous cell carcinoma of the larynx

Anticancer Res. 2006 May-Jun;26(3B):2493-7.

Abstract

Background: The aim of this study was to examine and compare the value of the serum tumor markers CYFRA 21-1, TPA-M, SCCA and CEA in squamous cell carcinoma (SCC) of the larynx. Moreover, their possible clinical applications were studied.

Materials and methods: The serum levels of CYFRA 21-1, TPA-M, SCCA and CEA were measured in 79 patients with histologically-proven squamous cell carcinoma (SCC) of the larynx before and after treatment and in 77 healthy volunteers. The association of the results with the clinicopathological characteristics was investigated.

Results: The study showed that none of the markers revealed a significant sensitivity; TPA-M indicated a positive correlation with the grade of differentiation. CEA indicated a positive correlation only with distant metastasis.

Conclusion: Among the four markers, only TPA-M may play a role in monitoring the success of therapy and follow-up in patients with SCC of the larynx.

MeSH terms

  • Adult
  • Aged
  • Antigens, Neoplasm / blood
  • Biomarkers, Tumor / blood*
  • Carcinoembryonic Antigen / blood
  • Carcinoma, Squamous Cell / blood*
  • Carcinoma, Squamous Cell / pathology
  • Cohort Studies
  • Female
  • Humans
  • Keratin-19
  • Keratins / blood
  • Laryngeal Neoplasms / blood*
  • Laryngeal Neoplasms / pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Serpins / blood
  • Tissue Polypeptide Antigen / blood

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Carcinoembryonic Antigen
  • Keratin-19
  • Serpins
  • Tissue Polypeptide Antigen
  • antigen CYFRA21.1
  • squamous cell carcinoma-related antigen
  • Keratins